MicroPort CardioFlow leases Shanghai production facilities under RMB 137.28 million deal

• MicroPort CardioFlow Medtech signed two five-year lease agreements for Shanghai industrial facilities, starting Aug. 1, 2026 through July 31, 2031.
• Total rent set at about RMB 137.28 million, split between heart valve production space and cardiac rhythm management manufacturing space.
• Right-of-use assets estimated at RMB 78.47 million for Lease I, RMB 40.23 million for Lease II under HKFRS 16.
• Security deposits set at about RMB 18.15 million and RMB 9.3 million, with refunds offset against rent due to prior deposits.
• Transaction classified as discloseable under Hong Kong listing rules, based on aggregated percentage ratios above 5% and below 25%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microport Cardioflow Medtech Corporation published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260802-12265543), on August 02, 2026, and is solely responsible for the information contained therein.